Death receptor 6

Source: Wikipedia, the free encyclopedia.
TNFRSF21
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_014452

NM_178589

RefSeq (protein)

NP_055267

NP_848704

Location (UCSC)Chr 6: 47.23 – 47.31 MbChr 17: 43.33 – 43.4 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Death receptor 6 (DR6), also known as tumor necrosis factor receptor superfamily member 21 (TNFRSF21), is a

white blood cells.[7] The Gene for DR6 is 78,450 bases long and is found on the 6th chromosome. This is transcribed into a 655 amino acid chain weighing 71.8 kDa. Post transcriptional modifications of this protein include glycosylation on the asparagines at the 82, 141, 252, 257, 278, and 289 amino acid locations.[8]

Function

The protein encoded by this gene is a member of the

TNF-receptor superfamily. This receptor has been shown to activate NF-κB and MAPK8/JNK, and induce cell apoptosis. Through its death domain, this receptor interacts with TRADD protein, which is known to serve as an adaptor that mediates signal transduction of TNF-receptors. Knockout studies in mice suggested that this gene plays a role in T helper cell activation, and may be involved in inflammation and immune regulation.[6] The DR6 is an alpha-helical integral membrane receptor protein that shows evidence that it has something to do with the inhibition of blood vessels forming on tumors which would allow them to grow larger. Death receptor 6 gets a chemical message and starts a signaling pathway that causes apoptosis, also known as cell death, to occur.[9] It is also expressed in endothelial cells. Tumor cells can induce, through exposition of amyloid precursor protein (APP), DR6-mediated endothelial cell necroptosis
allowing tumors metastasis.

Clinical significance

The free serum levels of this DR6 are heightened with anti-cell death factors in patients that have later stage ovarian cancer.[10]

DR6 is also thought to be involved in

Aβ and N-APP. N-APP is the fragment that interacts with DR6 to trigger axonal degradation in Alzheimer's patients.[12]
This pathway is essentially "hi-jacked" in the aging brain.

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000146072Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000023915Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. S2CID 11151198
    .
  6. ^ a b "Entrez Gene: TNFRSF21 tumor necrosis factor receptor superfamily, member 21".
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.